HOME › DRUGS › RESERPINE
ACTIVE SUBSTANCE / INN

RESERPINE

Brand name(s): SALUTENSIN-DEMI, RESERPINE, H.R.-50, HYDROFLUMETHIAZIDE AND RESERPINE, SALUTENSIN, SERPIVITE, HYDROCHLOROTHIAZIDE W/ RESERPINE, HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE, RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, CHLOROTHIAZIDE W/ RESERPINE
FDA LISTED
DISCONTINUED
NDA009645
ANDA085549
ACTIVE SUBSTANCE
Reserpine
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, IVAX SUB TEVA PHARMS, MYLAN
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEANDA085549WATSON LABSDiscontinued
HYDROFLUMETHIAZIDE AND RESERPINEANDA088110WATSON LABSDiscontinued
SERPIVITENDA009645VITARINEDiscontinued
SALUTENSINNDA012359SHIREDiscontinued
SALUTENSIN-DEMINDA012359SHIREDiscontinued
RESERPINEANDA080582PVT FORMDiscontinued
HYDROCHLOROTHIAZIDE W/ RESERPINEANDA083572IVAX SUB TEVA PHARMSDiscontinued
CHLOROTHIAZIDE W/ RESERPINEANDA084853WATSON LABSDiscontinued
H.R.-50ANDA085338WHITEWORTH TOWN PLSNDiscontinued
HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINEANDA087085MYLANDiscontinued

FULL INTELLIGENCE ON RESERPINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →